Category: Stock Market

Just when it looked like Xero shares might finally find some support, the selling has continued on Friday.

Xero Ltd (ASX: XRO) shares are currently down 3.21% to $57.125, having fallen as low as $56.22 earlier in the session.

That leaves the stock trading around 64% below its value 12 months ago and almost 50% lower in 2026.

And yet, I’m becoming increasingly bullish.

While the share price suggests something has gone terribly wrong, Xero’s underlying business continues to deliver impressive growth.

At these levels, I think investors could be looking at an excellent long-term buying opportunity.

Here’s why.

Xero’s business is still growing

Looking at Xero’s latest financial results, you’d be forgiven for wondering why its shares have fallen so far.

According to its FY26 results, operating revenue increased 31% to NZ$2.75 billion, while adjusted EBITDA climbed 18% to NZ$757.4 million.

The company also added 506,000 customers, taking its global customer base to 4.92 million.

Annualised monthly recurring revenue jumped 37% to NZ$3.27 billion, while free cash flow reached NZ$554 million.

Those are impressive numbers, particularly when you consider what’s happened to the share price.

Admittedly, net profit declined 27% to NZ$167.4 million, with acquisition-related costs weighing on earnings.

But I’m far more interested in where the business is heading over the next few years.

Management expects FY27 revenue of NZ$3.62 billion to NZ$3.73 billion, alongside adjusted EBITDA of NZ$860 million to NZ$920 million.

That’s another substantial increase in revenue, and a good indication that Xero’s growth story is far from over.

Why I’m bullish on Xero shares

I think investors are overlooking just how much growth Xero still has ahead of it.

The company has previously estimated its addressable market at approximately 100 million small and medium-sized businesses worldwide.

With fewer than 5 million customers today, there’s still an enormous opportunity to expand.

And it’s not just about attracting more subscribers.

Its acquisition of Melio gives Xero a stronger position in the US payments market, opening up another opportunity to grow revenue beyond accounting subscriptions.

I also think AI could make Xero’s platform more valuable over time by automating more of the financial tasks involved in running a small business.

The company already has an established platform, millions of customers, and access to valuable financial data.

With revenue expected to grow by around 30% in FY27, I think the market is seriously underestimating Xero’s long-term potential.

All in all, I see an excellent opportunity to buy a high-quality growth business at attractive levels.

The post Xero shares have crashed 64%. Here’s why I’m buying appeared first on The Motley Fool Australia.

More reading

• These 3 ASX 200 shares have lost 49%+ in 2026. Are any now bargains?
• Xero vs Life360: Which ASX tech share has more upside?
• Down 5% today to a 7-year low: What is going on with Xero shares?
• Should I invest $5,000 into WiseTech and Xero shares?
• How to build a $50,000 passive income from ASX shares

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Woolworths Group Ltd (ASX: WOW) shares have stormed higher through the first nine months of 2026.

At the time of writing on Friday afternoon, the shares are trading in the green, up around 1% to $38.51. 

The latest increase means the shares are now up an impressive 31% for the year to date, and they’re 44% higher than 12 months ago.

The increase has been pretty stable and consistent, too.

The supermarket giant’s stock has mostly trended upwards (with the exception of a dip in late April and a recovery a month later).

It looks like the growing share price is mostly driven by investor confidence that the company’s turnaround story is coming to fruition, after a difficult period in 2025.

The supermarket’s most recent price-sensitive news was the announcement of its impressive FY26 results in late August. It posted a 3.6% year-on-year increase in sales and a 6.7% increase in EBITDA (before significant items). On the bottom line, Woolworths achieved a 15.4% increase in its NPAT (before significant items) for the year.

As part of its FY26 results announcement, management declared a 52-cent per share dividend, up 15.6% from FY25.

It’s been tailwind after tailwind for Woolworths shares this year. Now the question is, is there any more upside left? Or has the ASX consumer staples stock finally reached a ceiling?

Buy, hold, or sell? Here’s what brokers forecast for Woolworths shares

The experts are divided.

Market Index data shows that brokers are split equally between a hold and a sell rating. The $37.57 average target price implies a potential 2% downside ahead.

On TradingView, the majority of analysts (nine out of 17) have a hold rating on the shares. Another six rate Woolworths shares are a sell/strong sell and two rate them as a buy.

The $39.67 average target price implies a potential 3% upside ahead. Although the range between the maximum and minimum is quite wide. Some tip the shares to fall 8% to $35.40, and others think they would increase 13% to $43.50, at the time of writing.

Shaw and Partners has a sell rating on Woolworths shares. The broker warns that the shares could struggle to outperform over coming months. It adds that the supermarket has experienced a strong recovery in the past year, and now much of the recent improvement is reflected in the share price.

Elsewhere, Bell Potter is more positive. The broker has a hold rating on Woolworths shares and a $42.35 target price. It was impressed with the company’s latest FY26 results but doesn’t think potential growth is high enough to warrant a buy rating.

Morgans has an accumulate rating and $43.50 target price. Following the supermarket’s results, the broker is more confident that its sales growth can be sustained.

The post Woolworths shares jump 31% in 2026. Is there any upside left? appeared first on The Motley Fool Australia.

More reading

• Here are the most popular ASX share superannuation investments in SMSFs
• Is the Woolworths share price a buy in September?
• How to build a $50,000 passive income from ASX shares
• Why these ASX dividend shares could be buys for passive income
• 5 ASX shares I’d recommend to beginners

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) gold stocks are getting ready to turn the calendar page on a tough month.

Indeed, while the ASX 200 has slumped 5.6% since market close on 25 August, the S&P/ASX All Ordinaries Gold Index (ASX: XGD) – which also contains some smaller miners outside of ASX 200 gold stocks – is down as steeper 8.3%.

Although most gold stocks have still strongly outperformed over the past full year, with the All Ords Gold Index still up 22.1% in 12 months, compared to the 1.4% one-year losses posted by the ASX 200.

As for the three big Aussie gold miners I’d buy today, Newmont Corp (ASX: NEM) shares are down 8% in a month and up 45.3% in a year, while Evolution Mining Ltd (ASX: EVN) shares are down 13.9% in a month and up 33.2% in a year.

It’s a bit of a different picture for Northern Star Resources Ltd (ASX: NST) shares, which are down 9.5% in a month and also down 2% in a year.

As you may know, Northern Star has faced some difficulties on and below the ground this year. Those include lower grades at some of its mines as well as lower overall gold production for FY 2026.

But I believe the miner’s recent capex spend is set to pay off in FY 2027 and 2028, which should see a notable improvement in the share price performance.

What’s been pressuring the ASX 200 gold stocks?

The common headwind pressuring Northern Star, Newmont, and Evolution Mining shares over the past month has been a sharp retrace in the gold price.

Trading for US$4,294 per ounce today, the gold price is down 7.7% since 25 August.

The gold price is now also down around 21% from its record highs, posted on 28 January.

A lot of that fall can be pinned on the outbreak of the Iran war. The conflict has sent global energy prices surging, stoking inflation and pushing central banks, including the US Federal Reserve and the RBA, to increase interest rates. And gold, which pays no yield itself, tends to perform better in low or falling rate environments.

But the case for higher gold prices remains very much in play, which could usher in a big rebound for the recently beaten-down ASX 200 gold stocks.

What are the experts saying?

Hedge fund manager Raphael Lamm, who manages a long-short gold fund, expects that the falling gold price is likely to be short-lived.

Among the reasons Lamm expects a rebound in the price of bullion, which would also support ASX 200 gold stocks, is the “unsustainability of fiscal situations in key markets,” with the United States government debt recently topping US$40 trillion.

According to Lamm (quoted by Bloomberg):

While there’s been some headwinds to gold markets and the gold price since the Iran war, we think they’re very temporary in nature. Most of the key drivers of demand for gold are going to remain intact or even strengthen over the medium term…

We started to increase our long positions relatively aggressively when the gold price got below $4,000, and now we’re keeping it where it is, which is in the low- to mid-60% net long.

The post Why I’d buy the dip in top ASX 200 gold stocks like Newmont, Northern Star and Evolution Mining shares today appeared first on The Motley Fool Australia.

More reading

• 5 ASX 200 shares upgraded by experts this week
• 5 things to watch on the ASX 200 on Friday
• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• $10,000 invested in Evolution Mining and Northern Star shares 3 years ago is now worth…

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Australia could be facing another two interest rate hikes before Christmas, and that has one economist worried.

According to The Australian, HSBC chief economist Paul Bloxham has warned that the Australian economy could be heading for a difficult few months.

He believes the Reserve Bank of Australia (RBA) may need to lift rates again, despite signs of slowing growth.

And if he’s right, Aussies could be facing more than just higher mortgage repayments.

With the RBA meeting next Tuesday, his latest outlook gives borrowers and investors plenty to think about.

So, just how worried should Australians be?

HSBC sees recession risk climbing

Bloxham believes the RBA has a strong case to lift interest rates next week, followed by another increase in November.

But he warns that two more hikes could leave the Australian economy struggling to grow around the turn of the year.

He expects economic growth to come close to stalling in the December and March quarters.

That has him putting the risk of a technical recession at close to 50%.

A technical recession occurs when the economy contracts for two consecutive quarters.

For comparison, Bloomberg’s surveyed recession probability over the next 12 months is currently just 20%.

So, why is Bloxham particularly concerned?

He points to Australia’s weak productivity growth, which has left the economy with very little room to expand without pushing inflation higher.

Bloxham believes growth may need to slow considerably, or the economy may need to contract.

He says this could be necessary to bring underlying inflation back to target by late 2027.

Why are more rate hikes expected?

The RBA has already increased interest rates 3 times this year, taking the cash rate to 4.35%.

However, inflation remains above the central bank’s 2% to 3% target.

The latest ABS inflation figures showed annual headline inflation at 3.5% in July, while trimmed mean inflation remained at 3.6%. 

Higher oil prices and global inflation pressures are adding to the RBA’s concerns.

Earlier this week, RBA governor Michele Bullock warned that inflation risks were materialising, although she stopped short of committing to another rate increase. 

Meanwhile, yesterday’s employment report showed Australia’s unemployment rate increasing to 4.6% in August.

Employment rose by 39,500 people, but full-time employment declined by approximately 6,000. 

Those figures suggest the labour market is cooling, but inflation remains a concern.

What happens next?

The RBA will announce its next interest rate decision on Tuesday, 29 September.

But there’s another complication.

August’s inflation figures aren’t due until Wednesday, one day after the board meets.

That means policymakers will have to make their decision without another inflation reading.

The post Could two more RBA rate hikes push Australia into recession? appeared first on The Motley Fool Australia.

More reading

• Why I’d buy the dip in top ASX 200 gold stocks like Newmont, Northern Star and Evolution Mining shares today
• ASX 200 sinks to June lows as investors brace for another RBA rate hike
• Why are Netwealth shares crashing 6% on Friday?
• Premier Investments vs Myer: Which ASX Retail Stock is Best?
• EOS shares jump 7% as ASX 200 falls. Could $15 be next?

HSBC Holdings is an advertising partner of Motley Fool Money. Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended HSBC Holdings. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It’s another rough Friday on the ASX, and things aren’t looking much better as we head towards the weekend.

The S&P/ASX 200 Index (ASX: XJO) is currently down 0.48% to around 8,659 points, after dropping as low as 8,639.9 earlier in the session.

That’s the lowest we’ve seen the benchmark since 11 June, with the index now down almost 5% over the past month.

And it’s not just a few of the big names dragging the market lower.

At the latest check, 155 stocks in the ASX 200 are falling, while just 39 are moving higher and 6 remain unchanged.

With another RBA interest rate decision coming up on Tuesday, investors have plenty to think about.

So, could things get worse next week?

Oil jumps as bond yields hit 19-year high

Wall Street was fairly quiet overnight, but there was lots happening in oil and bond markets.

The Dow Jones Industrial Average Index (DJX: .DJI) fell 0.31%, while the S&P 500 Index (SP: .INX) slipped 0.02%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) managed to finish 0.01% higher.

In addition, the US 10-year Treasury yield climbed to approximately 5.12%, its highest level in 19 years.

Oil prices were also on the move, with Brent crude jumping more than 4% overnight to around US$107.53 a barrel.

Selling spreads across the ASX 200

The selling is pretty widespread today, with 10 of the 11 ASX sectors trading lower.

BHP Group Ltd (ASX: BHP) shares are down 0.66% to $60.62, while Rio Tinto Ltd (ASX: RIO) has slipped 0.88% to $164.99.

Property-related stocks aren’t having a great day either, with REA Group Ltd (ASX: REA) falling 2.51% to $148.27.

However, the big banks are managing to buck the trend and provide some support for the benchmark.

Commonwealth Bank of Australia (ASX: CBA) shares are up 0.28% to $150.405, and Westpac Banking Corp (ASX: WBC) has gained 0.56% to $34.32.

Will the RBA make things worse next week?

All eyes now turn to Tuesday, when the RBA announces its next interest rate decision.

According to The Australian, money markets are pricing a 90% chance of another 25-basis point increase.

This would take the cash rate to 4.60%.

Traders are also pricing approximately 40 basis points of additional tightening by the end of the year.

The RBA has already lifted rates 3 times in 2026, and another increase would add to borrowing costs for households and businesses.

And with the ASX 200 at its lowest level since June, I’ll be watching whether it can hold above 8,600 points.

The post ASX 200 sinks to June lows as investors brace for another RBA rate hike appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• How to top up your superannuation if you’re 40 and falling behind
• Here are the top 10 ASX 200 shares today
• 6 ASX 200 shares scoring renewed buy calls this week
• ASX 200 slides as investors head for the exits. Is there more pain to come?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Just when Netwealth Group Ltd (ASX: NWL) shareholders thought things couldn’t get much worse, another problem has come their way.

Netwealth shares have plunged 5.72% to $17.47 in midday trade, after falling as low as $17.22 earlier in the session.

The wealth management stock has now lost more than 20% over the past month and is trading almost 50% below its 52-week high of $33.62.

And today’s announcement has given investors another reason to be concerned.

So, what has happened this time?

Netwealth faces class action

The selling follows an ASX announcement confirming that Netwealth is facing a class action over the failed First Guardian Master Fund.

The company revealed that two of its subsidiaries have now been served with a Statement of Claim.

At the centre of the case are First Guardian investment options offered through the Netwealth Superannuation Master Fund.

These were available to adviser-led members from March 2021, before Netwealth stopped accepting new investments in December 2022.

The company says it intends to defend the claim.

According to the release, the allegations cover matters previously addressed through a court-enforceable undertaking with ASIC.

The regulator accepted that undertaking in December 2025 and began Federal Court proceedings over the same issues.

Netwealth also reminded investors that it completed a compensation program in January 2026.

That saw around $101 million paid to affected members, covering the net capital each had invested in First Guardian.

What happened to investors’ money?

There was a lot of money tied up in First Guardian before things went wrong.

Between March 2021 and December 2022, 1,303 Netwealth members invested approximately $128.5 million in the fund.

Then, in May 2024, fund operator Falcon Capital froze withdrawals.

By that stage, around 1,080 members still had approximately $100.7 million invested.

The matter eventually ended up in the Federal Court.

In August, the court found that Netwealth’s subsidiaries had breached the Corporations Act in how they handled the investments.

They hadn’t gathered enough information about First Guardian or made adequate independent checks into the risks involved.

Members also weren’t warned that they might struggle to access their money if the fund became illiquid.

ASIC didn’t seek a financial penalty, pointing to Netwealth’s timely compensation of affected investors.

What’s next for Netwealth shares?

Netwealth has already paid around $101 million in compensation, but it still has another legal battle on its hands.

And there’s still the question of what this latest case could mean financially.

With shares continuing to fall, investors clearly aren’t thrilled about another round of legal proceedings.

Personally, I wouldn’t rush in just because the stock has fallen so far.

The post Why are Netwealth shares crashing 6% on Friday? appeared first on The Motley Fool Australia.

More reading

• Netwealth faces class action after compensation payments
• 3 ASX shares down 40% to 80% I’d buy on the cheap
• Buy, hold, sell: Netwealth, Tabcorp, Healius shares
• Should I buy Coles shares for passive income?
• 2 ASX 200 shares to buy and 1 to sell now

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Premier Investments vs Myer Holdings shares: which ASX retailer stacks up best?

When everyday investors look for steady returns and income from retail stocks, Premier Investments Ltd (ASX: PMV) and Myer Holdings Ltd (ASX: MYR) are frequent contenders. Both are household names on the ASX with passionate customer followings and large store footprints, but their investment cases have diverged after a major restructuring. If you’re deciding between Premier Investments and Myer shares, here’s how the fundamentals compare right now.

The case for Premier Investments

Premier Investments is a specialist retail group now focused on two leading brands: Peter Alexander, a premium sleepwear and home lifestyle name, and Smiggle, a much-loved children’s stationery retailer famous for its colourful products. After spinning off its apparel chains (like Just Jeans and Jay Jays) to Myer in 2025, Premier now embraces a simpler model that’s less exposed to discount apparel cycles and more to lifestyle and gift-buying. It still retains a large shareholding in Myer.

Highlights of Premier Investments right now:

• Strong dividend yield: Premier is offering an attractive 8.51% dividend yield, all fully franked. Its dividend per share sits at $0.95, a show of confidence in returning capital.
• Solid profitability: With earnings per share of $0.902 and a P/E ratio of 12.38, Premier trades on markedly lower earnings multiples than Myer at present.
• Resilience through refocus: The company has pivoted to two brands with defensible niches (sleepwear and kids’ stationery), and international growth potential continues with Smiggle and Peter Alexander’s expansion into the UK and Asia, according to its company profile.

The case for Myer Holdings

Myer is one of Australia’s largest department store operators, now even bigger following its acquisition of Premier’s former apparel brands (Just Jeans, Jay Jays, Portmans, Dotti, and Jacqui E) in 2025. Alongside its network of around 60 MYER-branded department stores (as of its public company description), Myer now controls a vast stable of retail brands with national reach, targeting value-conscious fashion and home shoppers across the country.

Key considerations for Myer Holdings today:

• High yield for income seekers: Myer’s dividend yield edges out Premier’s at 8.57%, fully franked, with a current dividend per share of $0.02 as per the latest data.
• Wider retail footprint: Myer now operates both large format department stores and hundreds of specialty apparel outlets. This broad network potentially diversifies sales streams and brand risks.
• Turnaround challenge: Myer’s recent financials show strain after integration: it records a negative earnings per share of -$0.178 and carries a higher P/E ratio of 23.70. Note: Myer’s reported P/E ratio may be based on a different earnings measure (e.g. underlying or forward earnings) than the EPS figure shown, which is why they may appear inconsistent.

Valuation comparison

Here’s how key metrics stack up side by side for income, value, and risk:

	Premier Investments	Myer Holdings
Market Cap	$1.91 billion	$337.50 million
P/E Ratio	12.38	23.70
Earnings per Share	$0.902	-$0.178
Dividend Yield	8.51% (100% franked)	8.57% (100% franked)

Premier is the much larger business by market cap and currently trades at a far lower P/E ratio, supported by positive earnings. Myer, despite a slightly higher yield, has negative EPS at the latest read and a notably higher multiple—usually a signal investors expect future profit recovery, but with added risk.

Recent share price performance

Comparing recent momentum using both companies’ closing prices as of 23 September 2026:

• Premier Investments closed at $11.95, up 7.08% on the day, but its year-to-date return sits at -15.8%.
• Myer Holdings closed at $0.18, unchanged for the day, but its year-to-date return is -60.0%.

So while both shares are down for 2026, Myer has dramatically underperformed Premier over the year, with its stock falling much further.

Which is the better buy?

Looking at both the numbers and the business setup, I think Premier Investments makes the stronger case at present. It’s profitable, sports a healthy fully franked yield, and is trading on a much lower P/E ratio than Myer. Its focus on brands with pricing power and some international growth runway adds conviction. By contrast, Myer faces a tough turnaround task post-demerger, with negative earnings and a much weaker share price, despite its large footprint and similar headline yield. If I had to pick a retail stock between these two today, my choice would be Premier Investments.

The post Premier Investments vs Myer: Which ASX Retail Stock is Best? appeared first on The Motley Fool Australia.

More reading

• This ASX 200 share offers 30% upside and a 7% yield
• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX 200 shares today
• Down 64%: Has the market lost interest in Myer shares?
• Why are Premier Investments shares trading higher today?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Myer and Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

It’s been a difficult Friday for Australian investors, but Electro Optic Systems Holdings Ltd (ASX: EOS) shareholders have plenty to smile about.

While the S&P/ASX 200 Index (ASX: XJO) is down 0.54% to 8,655 points, EOS shares are heading in the opposite direction.

The defence tech company’s shares have jumped 7.21% to $11.45, putting it within striking distance of its 52-week high of $12.58.

And with another opportunity opening up in the US defence market, there’s plenty for investors to get excited about.

So, could $15 be the next stop?

EOS unlocks a new US defence opportunity

According to the latest company update, EOS has secured a new procurement pathway for its R400 remote weapon system (RWS).

The system is now listed on the US Joint Interagency Task Force 401 Counter-UAS marketplace.

It allows eligible US government customers to compare counter-drone tech and purchase it through an established US Army contracting arrangement.

Access is also expanding to other allied nations, with 23 countries currently cleared to participate.

The R400 is designed to track and engage ground threats, along with small and medium-sized drones.

While the listing doesn’t represent a new contract, it puts EOS in front of more potential customers and makes the buying process easier.

That’s a pretty good position to be in, particularly as demand for counter-drone tech continues to grow.

I think this could become a valuable sales channel, especially if EOS can turn that additional exposure into more signed contracts.

The numbers are backing it up

It’s not just the growing sales opportunities that have me feeling bullish about EOS.

The company’s latest half-year results showed revenue surged 283% to $168.8 million, compared with $44.1 million a year earlier.

Underlying EBITDA also swung from a $14.9 million loss to a $21.6 million profit.

But what really catches my attention is the company’s order book, which reached a record $846 million at the end of June.

That’s a substantial amount of business already secured, giving EOS plenty of work to deliver over the coming years.

Management is now forecasting full-year revenue of between $360 million and $400 million, including its recently acquired MARSS business.

If achieved, that would represent record annual revenue for the company.

Could EOS shares reach $15?

I think there’s a strong case for further upside, particularly if EOS can turn its growing pipeline into more signed contracts.

And I’m not the only one looking at $15.

According to TipRanks, Canaccord Genuity has a buy rating and $15 price target, while Bell Potter and Ord Minnett have targets of $12.60 and $12.50, respectively.

From $11.45, Canaccord’s $15 target points to potential upside of more than 30%.

Personally, I’d still be comfortable buying EOS shares at these levels with a long-term investment horizon.

The post EOS shares jump 7% as ASX 200 falls. Could $15 be next? appeared first on The Motley Fool Australia.

More reading

• Electro Optic Systems vs Droneshield: Which ASX defence share wins?
• Here are the top 10 ASX 200 shares today
• Could this ASX defence stock rocket back above $13 before Christmas?
• Top 3 ASX defence shares to buy right now
• 4 ASX shares I’d buy with $5,000 in September

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

UBS has issued new research reports this week and has identified two companies with market-moving news they think are worth a look.

Let’s see who they like.

Nufarm Ltd (ASX: NUF)

Nufarm shares are up by more than a third over the past 12 months but UBS believes the stock still has a way to run.

The company this week put out new earnings guidance, saying it expected underlying EBITDA to increase by about 25% for the full year.

The company’s seed technologies division was expected to deliver strong growth, led by growth in hybrid seeds and improved omega-3 pricing.

The company’s crop protection division however was expected to have flat earnings.

On the negative side of the ledger Nufarm said it expected to book $90-$110 million in write downs.

UBS said the expected result was a 2%-3% downgrade to previous expectations.

The broker has a price target of $3.50 on Nufarm shares compared to $3.12 currently.

Telix Pharmaceuticals Ltd (ASX: TLX)

UBS has a very bullish price target on Telix after attending an R&D day which the broker said, “showcased the meaningful clinical development for TLX’s diagnostics and therapeutics pipeline across prostate, brain, and kidney cancers”.

The broker said key highlights included progress on prostate cancer therapeutics as well as the company’s Pixclara brain cancer imaging agent.

UBS said:

We believe the event further highlighted TLX’s growing breadth and depth across precision medicine and therapeutics towards being a leading radiopharma business. We see multiple opportunities for meaningful value creation on the horizon, supported by TLX’s deep expertise and clinical development experience with key catalysts over the next 12 months being resubmission/approval for Zircaix, topline data from BiPASS, topline data for TLX597, and data updates from ProstAct Global trial. Furthermore, we believe the recent deal with ITM improves isotope supply chain for ongoing therapeutic portfolio development, creates cost synergy, and adds additional therapeutic pipelines.

Telix just this week announced the $3.3 billion merger deal with ITM, which, Telix said, is the world’s leading supplier of therapeutic radioisotopes and the only producer of globally-scaled, commercial-grade lutetium-77.

Telix said regarding the deal:

The merger will further strengthen Telix’s leadership as a vertically integrated radiopharmaceutical company with the capabilities required to develop, manufacture and deliver innovative treatments to patients globally. The combined organisation will be uniquely positioned as a radiopharmaceutical industry leader, differentiated by a world-class scaled isotope manufacturing business with a validated global distribution network, a market-leading commercial precision medicine platform and the industry’s most extensive therapeutic radiopharmaceutical pipeline.

Telix said ITM grew at a compound annual rate of 40% from 2021 to 2025 and generated US$273 million in revenue in 2025.

UBS has a price target of $22 on Telix shares compared to the current price of $16.01.

The post 2 ASX shares UBS says could increase 13% to 37% appeared first on The Motley Fool Australia.

More reading

• 5 ASX 200 shares upgraded by experts this week
• Buy, hold, sell: New Hope, REA, Telix Pharmaceuticals shares
• What is Bell Potter’s updated view on Nufarm shares after crashing 6%
• 5 things to watch on the ASX 200 on Thursday
• Why is this ASX share crashing 8% on Wednesday?

Motley Fool contributor Cameron England has positions in Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Bank of Queensland Ltd (ASX: BOQ), Harvey Norman Ltd (ASX: HVN) and Lynas Rare Earths Ltd (ASX: LYC) shares are in focus today amid a combination of analyst updates and shifting investor sentiment.

Let’s find out how these stocks are tracking, and what brokers expect next.

Brokers rate Lynas shares as a BUY

Lynas shares have fallen around 2% in Friday morning trade, to $14.10 a piece. The shares are now up around 15% for the year-to-date but are 17% below trading levels 12 months ago.

The downturn is down to a couple of factors which have combined to create headwinds for the ASX rare earths miner. Geopolitical volatility, higher costs, and investors taking their gains off the table after a strong rally earlier this year, have all dampened the share price.

But late last month the company posted a record FY26 profit and revenue as company growth continues to ramp up. Lynas reported a 76% increase in revenue and a 282% increase in EBITDA. 

The company also confirmed it is focused on ramping up new assets in FY27, and growing its global presence.

It looks like analysts are excited by Lynas’ potential. TradingView data shows the majority have a buy/strong buy rating on the shares. The average $19.57 target price implies a 39% upside, at the time of writing.

Brokers rate Harvey Norman shares as a HOLD

Harvey Norman shares are flat at $4.17 this morning. It’s been a difficult year for the retailer and its shares have shed 41% of their value so far in 2026. They’re also 43% lower than 12 months ago.

Harvey Norman has faced strong headwinds this year following renewed concerns about rising inflation and its impact on consumer spending. A tighter household budget means Australians have lowered their discretionary spending this year. 

The experts are on the fence about where the shares could go over the next 12 months. TradingView data shows six (out of 14) analysts have a hold rating on Harvey Norman. Another five rate the shares a sell/strong sell and three rate the shares as a buy/strong buy.

The $4.46 average target price implies a potential 7% upside ahead, at the time of writing.

Brokers rate BOQ shares as a SELL

BOQ shares have been relatively stable through September so far hovering between $6.50 and $6.70 a piece. It’s good news for investors after the ASX bank shares were caught up in a bank-sector-wide sell-off last month. 

At the time of writing the shares are also flat at $6.51 a piece. The shares are now down around 1% for the year-to-date and 9% lower than 12 months ago.

The bank is scheduled to post its FY26 results in three weeks time (on the 15th of October) and it looks like investors are sitting tight while they wait for an update on the bank’s revenue, net interest margin and final dividend call.

It looks like the shares are still considered to be trading above fair value. TradingView data shows the majority have a sell/strong sell rating on the shares. The $6.09 average target price implies a downside of around 6% at the time of writing. 

The post Buy, hold, sell: BOQ, Harvey Norman, Lynas shares appeared first on The Motley Fool Australia.

More reading

• How much superannuation do I need to earn $1,000 per week in passive income?
• Bank of Queensland shares hit a 52-week low in June. Are they cheap today?
• Downgrade alert! 5 ASX 200 shares downgraded by experts this week
• ASX retail shares are down 13% in 2026. Here’s what Morgan Stanley is worried about
• Starting with $20,000, how to build a portfolio generating $5,000 a year in passive income

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.